Commitments and Contingencies - Additional Information (Detail) (USD $)	1 Months Ended	0 Months Ended			1 Months Ended				12 Months Ended		0 Months Ended		1 Months Ended	0 Months Ended	1 Months Ended		0 Months Ended	1 Months Ended					0 Months Ended				1 Months Ended					0 Months Ended	1 Months Ended
	Jan. 23, 2015	Oct. 07, 2014	Aug. 13, 2014	Feb. 04, 2014	Jul. 27, 2014	Feb. 20, 2014	Nov. 30, 2013	Jan. 20, 2011	Dec. 31, 2014	Dec. 31, 2013	Mar. 12, 2014	Oct. 08, 2014	Jun. 27, 2014	Oct. 04, 2010	Sep. 24, 2014	Jul. 23, 2014	Jun. 16, 2014	Oct. 23, 2014	Oct. 31, 2014	Mar. 12, 2014	Aug. 27, 2014	Jun. 15, 2012	May 09, 2014	Mar. 14, 2014	Jul. 02, 2013	Jun. 10, 2013	Mar. 27, 2013	Jul. 22, 2014	Dec. 23, 2013	Mar. 20, 2013	Mar. 22, 2013	Feb. 11, 2014	Aug. 25, 2014 sqft
Commitments and Contingencies Disclosure [Line Items]
Grant date value		$ 15,000				$ 67,830			$ 124,200
Warrant exercisable term						3 years
Lease Expiration Date								Jan. 31, 2014
Lease Rent Second Year									6,234
Lease Rent Third Year									6,422
Research and Development Expense									1,430,614	1,594,054
Accounts Payable and Accrued Liabilities, Total									43,000	353,000
Stock issued during period, value, issued for services		48,388
Stock-based compensation, stock option granted						500,000			10,575,000	1,145,000
Common stock exercise price						$ 0.32			$ 0.41	$ 0.68
Number of shares called by warrants									190,000	402,500
Initial year Salary		25,000
Percentage Of Increase Salary		28.00%
Employee-related Liabilities									574,278	542,535
Salaries, Wages and Officers Compensation, Total										565,000
Loss Contingency, Damages Paid, Value							193,000
Loss contingency damages paid value, warrants issued							80,000
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.75
Monthly Payments for Leasing				962
Stock Issued During Period, Shares, New Issues			550,000
Leasehold Improvements, Gross									103,582	0
Rent Expense									20,380	99,175
Professional Fees									1,310,121	779,462
Monthly Payments under Consulting Agreements		15,000			10,000
Monthly Escalating Payments under Consulting Agreements		10,000
Warrants Issued During Period, Number of Warrants	100,000
Share Based Compensation									1,360,296	812,647
Security Deposit									45,900	0
Loss Contingency Damages Paid Value Per Year							52,000
Loss Contingency, Allegations							The action is associated with an alleged $5,000 loan made in 2009 and an alleged consulting/employment agreement entered into with the Company effective in 2009.
Warrants Issue One [Member]
Commitments and Contingencies Disclosure [Line Items]
Warrants Issued During Period, Number of Warrants											100,000
Warrants Issued During Period, Exercise Price at Issuance Date											$ 0.53									0.53
Warrants Issue Two [Member]
Commitments and Contingencies Disclosure [Line Items]
Warrants Issued During Period, Number of Warrants											280,000
Warrants Issued During Period, Exercise Price at Issuance Date											$ 0.53									0.53
Warrants Issue Three [Member]
Commitments and Contingencies Disclosure [Line Items]
Warrants Issued During Period, Number of Warrants											20,000
Warrants Issued During Period, Exercise Price at Issuance Date											$ 1.50									1.50
Chief Medical Advisor [Member]
Commitments and Contingencies Disclosure [Line Items]
Stock-based compensation, stock option granted						300,000
Common stock exercise price						$ 0.65
Monthly Payments under Consulting Agreements						10,000						15,000
Monthly Escalating Payments under Consulting Agreements						20,000						20,000
Warrant [Member]
Commitments and Contingencies Disclosure [Line Items]
Grant date value											23,270									23,270
Allocated Share-Based Compensation Expense											30,096
Common Stock [Member]
Commitments and Contingencies Disclosure [Line Items]
Stock Issued During Period, Shares, Other									595,455
Subsequent Event
Commitments and Contingencies Disclosure [Line Items]
Warrant issued for the purchase of common stock									80,000
Minimum
Commitments and Contingencies Disclosure [Line Items]
Warrants exercise price									$ 0.30	$ 1.50
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.50	$ 0.94
Maximum
Commitments and Contingencies Disclosure [Line Items]
Warrants exercise price									$ 0.75	$ 4.00
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.75	$ 2.50
Director
Commitments and Contingencies Disclosure [Line Items]
Warrant issued for the purchase of common stock													600,000
Grant date value													144,000
Stock options granted exercise price per share													$ 0.285
Number of shares vest on first anniversary of date of grant													200,000
Number of shares vest on second anniversary of date of grant													200,000
Number Of Shares Vest On Third Anniversary Of Date Of Grant													200,000
Chief Executive Officer
Commitments and Contingencies Disclosure [Line Items]
Employee-related Liabilities										25,000
Salaries, Wages and Officers Compensation, Total									450,000	600,000				600,000
Salary Reduced									450,000	360,000
Salary Bonus										300,000
Chief Executive Officer | Subsequent Event
Commitments and Contingencies Disclosure [Line Items]
Salaries, Wages and Officers Compensation, Total									450,000
Salary Reduced									400,000
Consultant
Commitments and Contingencies Disclosure [Line Items]
Stock issued during period shares for services																30,000
Stock issued during period, value, issued for services									33,000
Stock-based compensation, stock option granted															75,000		60,000
Common stock exercise price															$ 0.33		$ 0.39
Number of shares immediately vest on date of grants									150,000
Non Employee Director Awards
Commitments and Contingencies Disclosure [Line Items]
Accounts Payable and Accrued Liabilities, Total									105,000	130,000
Board of Directors
Commitments and Contingencies Disclosure [Line Items]
Salaries, Wages and Officers Compensation, Total													80,000
Compensation Paid To Directors Aggregate Amount													30,000
Compensation Paid To Directors Instalment Amount													50,000
Share Based Compensation													96,250
Employees and Directors
Commitments and Contingencies Disclosure [Line Items]
Grant date value									15,000
Stock issued during period, value, issued for services																			5,000
Stock-based compensation, stock option granted									36,786									5,950,000		2,415,000
Common stock exercise price																		$ 0.33
Monthly Payments under Consulting Agreements																			10,000
Employees and Directors | Minimum
Commitments and Contingencies Disclosure [Line Items]
Common stock exercise price																				0.53
Employees and Directors | Maximum
Commitments and Contingencies Disclosure [Line Items]
Common stock exercise price																				0.65
Business Advisory Services
Commitments and Contingencies Disclosure [Line Items]
Stock-based compensation, stock option granted																					300,000
Business Advisory Services | Extension 1
Commitments and Contingencies Disclosure [Line Items]
Warrant exercisable term					5 years
Marketing Consulting Services
Commitments and Contingencies Disclosure [Line Items]
Warrant issued for the purchase of common stock					250,000
Exercise price of warrant					$ 1.00
Marketing Consulting Services | Consultant
Commitments and Contingencies Disclosure [Line Items]
Contractual Obligation					65,000
Consulting Expense In Shares					500,000
Business Advisory Services Immediately Vesting
Commitments and Contingencies Disclosure [Line Items]
Consulting expense																					75,000
August 16, 2015
Commitments and Contingencies Disclosure [Line Items]
Number of shares vest on first anniversary of date of grant													150,000
August 16, 2016
Commitments and Contingencies Disclosure [Line Items]
Number of shares vest on second anniversary of date of grant													150,000
Assignment Agreement
Commitments and Contingencies Disclosure [Line Items]
Cash payment in exchange for patents																						15,000
Percentage of royalty agreed to be paid																						5.00%
Royalty Period																						20 years
Research and Development Arrangement
Commitments and Contingencies Disclosure [Line Items]
Cash payment in exchange for patents																						500,000
Percentage of royalty agreed to be paid																						5.00%
Royalty Period																						20 years
Research and Development Expense									264,000	500,000
Professional Fees									323,336														208,335
Accrued Professional Fees																							104,168
Gain On Settlement Related To Agreement																							166,668
Agreement Expiration Date																							Jun. 14, 2015
Research and Development Arrangement | Minimum
Commitments and Contingencies Disclosure [Line Items]
Fees payable for services per month																							20,000
Research and Development Arrangement | Maximum
Commitments and Contingencies Disclosure [Line Items]
Fees payable for services per month																							41,667
Marketing Consulting Services Agreement
Commitments and Contingencies Disclosure [Line Items]
Warrant exercisable term													5 years
Consulting expense									82,500	120,000
Marketing Consulting Services Agreement | Warrant [Member]
Commitments and Contingencies Disclosure [Line Items]
Grant date value					37,500
Marketing Consulting Services Agreement | Common Stock [Member]
Commitments and Contingencies Disclosure [Line Items]
Grant date value					110,000
Business Advisory Services | Extension 1
Commitments and Contingencies Disclosure [Line Items]
Warrant issued for the purchase of common stock					250,000
Exercise price of warrant					$ 1.00
Grant date value					37,500
Additional Monthly Fee For Services Rendered					16,667
Business Advisory Services | Extension 2
Commitments and Contingencies Disclosure [Line Items]
Warrant issued for the purchase of common stock					100,000
Exercise price of warrant					$ 0.50
Grant date value					17,000
Additional Monthly Fee For Services Rendered					15,000
Consulting expense									150,000	120,000
Chief Executive Officer Employment Agreements
Commitments and Contingencies Disclosure [Line Items]
Restructuring Reserve, Current									175,000
Scientific Advisory Services
Commitments and Contingencies Disclosure [Line Items]
Grant date value																								5,860	47,960		45,900
Warrant exercisable term													10 years											5 years	10 years	5 years	10 years
Recognized granted fair value award																										2,056
Total options granted					300,000																			25,000	100,000	5,000	60,000
Stock options granted exercise price per share					$ 0.285																			$ 0.50	$ 1.00	$ 1.00	$ 1.50
Number of shares immediately vest on date of grants					81,000																			5,000			30,000
Number of shares vest on first anniversary of date of grant																								12,500	50,000
Number of shares vest on second anniversary of date of grant																								12,500	50,000		30,000
Other
Commitments and Contingencies Disclosure [Line Items]
Warrant issued for the purchase of common stock																												10,000	100,000	10,000	100,000
Grant date value																												1,500	16,770	6,600	59,000
Warrant exercisable term																												5 years	5 years	3 years	5 years
Additional vested common stock shares									474,373	129,537
Additional Vested Common Stock Value									159,837	77,555
Warrants exercise price																												$ 0.75	$ 2.00	$ 1.50	$ 4.00
Stem Cell Treatment Company
Commitments and Contingencies Disclosure [Line Items]
Monthly Payments for Leasing																																100
Payments for Leasing Per Day																																3,750
Melville Lease
Commitments and Contingencies Disclosure [Line Items]
Number of shares called by warrants																																	142,100
Class of Warrant or Right, Exercise Price of Warrants or Rights																																	$ 0.50
Land Subject to Ground Leases																																	6,800
Land Lease Term																																	63 months
Stock Issued During Period, Shares, Other																																	284,200
Description Of Leasing Arrangement Consideration																																	(i) $60,000 towards the leasehold improvements of the leased premises and (ii) $11,050 of prepaid rent for the fifth month of the lease.
Stock Issued During Period, Shares, New Issues									71,050
Leasehold Improvements, Gross									60,000
Prepaid Rent									11,050
Security Deposit									45,900
Melville Lease | Minimum
Commitments and Contingencies Disclosure [Line Items]
Accrued Rent																																	132,600
Melville Lease | Maximum
Commitments and Contingencies Disclosure [Line Items]
Accrued Rent																																	$ 149,260